ROHTO PHARMACEUTICAL CO.,LTD.

4527

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-06FY2027 Q1

Revenue

3533.8100M JPY

YoY +9.7%

Operating Income

136.6100M JPY

YoY +16.8%

Net Income

331.3100M JPY

YoY -3.4%

EPS

47.1JPY

YoY -9.5%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

3437.3億円

2577.9億円

1718.6億円

859.3億円

Rev: 1996.5億円Op: 293.5億円NI: 210.2億円

Rev: 2386.6億円Op: 339.6億円NI: 263.8億円

Rev: 2708.4億円Op: 400.5億円NI: 309.4億円

Rev: 3086.3億円Op: 389.4億円NI: 310.1億円

Rev: 3437.3億円Op: 411.2億円NI: 342.5億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income30.3%

Revenue Progress916.200M

Revenue Forecast372300M

Net Income Progress106.500M

Net Income Forecast35200M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan